Cardiac Toxicity Associated with Capecitabine Therapy

Author： Wasif Saif M.   Quinn Mary G.   Thomas Rebecca R.   Ernst Aaron   Grem Jean L.  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.42, Iss.4, 2003-01, pp. : 342-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac Toxicity of Antineoplastic Anthracyclines

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 2, 2003-03 ,pp. : 151-171

Bentham Science Publishers

Access to resources Recommend Favorite

Capecitabine: As Adjuvant Therapy in Stage III Colon Cancer

By Robins Gayle W.   Keating Gillian M.  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

Myelopathy After Radiation Therapy and Chemotherapy with Capecitabine and Gemcitabine

By Barstis John   Black Alexander  

Cancer Investigation, Vol. 23, Iss. 7, 2005-10 ,pp. : 596-598

Informa Healthcare

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite

Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer

By                    

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2598-2602

Spandidos Publications

Access to resources Recommend Favorite